Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients with Nonobstructive Hypertrophic Cardiomyopathy

OBJECTIVES: To evaluate the effects of losartan on left ventricular (LV) hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy (HCM). BACKGROUND: Despite evidence that myocardial hypertrophy and fibrosis are mediated by angiotensin II and are important determinants of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shimada, Yuichi J., Passeri, Jonathan J., Baggish, Aaron L., O’Callaghan, Caitlin, Lowry, Patricia A., Yannekis, Gia, Abbara, Suhny, Ghoshhajra, Brian B., Rothman, Richard D., Ho, Carolyn Y., Januzzi, James L., Seidman, Christine E., Fifer, Michael A.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950308/
https://ncbi.nlm.nih.gov/pubmed/24621999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2013.09.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars